enVVeno Medical Corp reports results for the quarter ended June 30 - Earnings Summary

• enVVeno Medical Corp NVNO.OQ reported a quarterly adjusted loss of 33 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -31 cents. The lone analyst forecast for the quarter was for a loss of 28 cents per share.

• Reported revenue was zero​; analysts expected zero.

• enVVeno Medical Corp's reported EPS for the quarter was a loss of 33 cents​.

• The company reported a quarterly loss of $6.69 million.

• enVVeno Medical Corp shares had risen by 15.5% this quarter and gained 52.6% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had risen by about 6.7% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is "buy."

• Wall Street's median 12-month price target for enVVeno Medical Corp is $12.50, about 63.1% above its last closing price of $4.61

This summary was machine generated from LSEG data August 1 at 03:05 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)